I agree that this site is using cookies. You can find further informations here.
X
Abruzzese E
209  results:
Search for persons X
?
1

Ruxolitinib Adherence in Myelofibrosis and Polycythemia Ver..:

Palandri, F. ; Auteri, G. ; Abruzzese, E....
Annals of Hematology.  103 (2024)  6 - p. 1931-1940 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Treatment discontinuation following low-dose TKIs in 248 ch..:

Iurlo, A. ; Cattaneo, D. ; Consonni, D....
Frontiers in Pharmacology.  14 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS W..:

Apperley, J. ; Kantarjian, H. ; Deininger, M....
HemaSphere.  6 (2022)  - p. 602-603 , 2022
Link: https://doi.org/10.1097/..
 
?
4

S111: REPEATED INFUSIONS OF ESCALATING DOSES OF EXPANDED AN..:

Torelli, G. F. ; Chiaretti, S. ; Peragine, N....
HemaSphere.  6 (2022)  - p. 12-13 , 2022
Link: https://doi.org/10.1097/..
 
?
5

P1706: CLINICAL UTILITY OF ONLINE MONITORING OF PATIENT-REP..:

Efficace, F. ; Cottone, F. ; Yanez, B....
HemaSphere.  6 (2022)  - p. 1587-1588 , 2022
Link: https://doi.org/10.1097/..
 
?
6

S156: INTERNATIONAL, PROSPECTIVE STUDY COMPARING NILOTINIB ..:

Pane, F. ; Castagnetti, F. ; Luciano, L....
HemaSphere.  6 (2022)  - p. 57-58 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P698: BOSUTINIB DOSE OPTIMIZATION IN THE SECOND-LINE TREATM..:

Castagnetti, F. ; Bocchia, M. ; Abruzzese, E....
HemaSphere.  6 (2022)  - p. 593-594 , 2022
Link: https://doi.org/10.1097/..
 
?
8

P712: ASCIMINIB ITALIAN MANAGED ACCESS PROGRAM: EFFICACY PR..:

Breccia, M. ; Russo Rossi, A. V. ; Martino, B....
HemaSphere.  6 (2022)  - p. 607-608 , 2022
Link: https://doi.org/10.1097/..
 
?
9

Bosutinib for pretreated patients with chronic phase chroni..:

Hochhaus, Andreas ; Gambacorti-Passerini, Carlo ; Abboud, Camille...
Leukemia.  34 (2020)  8 - p. 2125-2137 , 2020
Link: https://doi.org/10.1038/..
 
?
10

Clinical impact of low-burden BCR-ABL1 mutations detectable..:

Soverini, S ; De Benedittis, C ; Papayannidis, C...
Leukemia.  30 (2016)  7 - p. 1615-1619 , 2016
Link: https://doi.org/10.1038/..
 
?
11

Managing chronic myeloid leukaemia in the elderly with inte..:

Russo, D ; Malagola, M ; Skert, C...
Blood Cancer Journal.  5 (2015)  9 - p. e347-e347 , 2015
Link: https://doi.org/10.1038/..
 
?
12

Severe Peripheral Arterial Disease During Nilotinib Therapy:

Le Coutre, P. ; Rea, D. ; Abruzzese, E....
JNCI Journal of the National Cancer Institute.  103 (2011)  17 - p. 1347-1348 , 2011
Link: https://doi.org/10.1093/..
 
?
13

Conversion to Rapamycin Immunosuppression for Malignancy Af..:

Iaria, G. ; Anselmo, A. ; De Luca, L....
Transplantation Proceedings.  39 (2007)  6 - p. 2036-2037 , 2007
Link: https://doi.org/10.1016/..
 
?
14

A phase-II trial of all trans retinoic acid and low-dose cy..:

Venditti, A. ; Tamburini, A. ; Buccisano, F....
Annals of Hematology.  79 (2000)  3 - p. 138-142 , 2000
Link: https://doi.org/10.1007/..
 
?
15

Progression of a myelodysplastic syndrome to pre-B acute ly..:

Abruzzese, E. ; Buss, D. ; Rainer, R...
Annals of Hematology.  73 (1996)  1 - p. 35-38 , 1996
Link: https://doi.org/10.1007/..
 
1-15